Key result
Oral rivaroxaban dramatically improved deep vein thrombosis that had worsened during treatment with low-molecular-weight heparin in a patient with eosinophilic granulomatosis with polyangiitis.
Why the study?
Does oral rivaroxaban improve thrombosis uncontrolled by LMWH in a patient with eosinophilic granulomatosis with polyangiitis?
Case Report (n=1)
Does oral rivaroxaban improve thrombosis uncontrolled by LMWH in a patient with eosinophilic granulomatosis with polyangiitis?
Oral rivaroxaban may be an effective treatment for thrombosis uncontrolled by LMWH in patients with eosinophilic granulomatosis with polyangiitis.
A 41-year-old woman presented complaining of cough and purpura for one month. On her first visit, a blood test demonstrated peripheral blood eosinophilia, but chest radiography showed no abnormalities. However, 2 days after the first visit, she went to the emergency room because of fever and right-sided chest pain. Contrast-enhanced computed tomography of the chest showed pulmonary embolism and air space consolidation. Thrombosis was present in the popliteal vein. Bronchoscopy revealed alveolar hemorrhage and increased eosinophils in the bronchoalveolar lavage fluid, and a skin biopsy demonstrated a perivascular eosinophilic infiltrate. The patient was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). We started steroid therapy and low-molecular-weight heparin (LMWH). The chest pain and fever disappeared, and the peripheral eosinophil count normalized. However, the thrombosis in the leg worsened. It was dramatically improved by changing from LMWH to oral rivaroxaban. The thrombogenic risk of eosinophilia should be recognized. This case suggests that oral rivaroxaban is useful when thrombosis is uncontrolled by LMWH in a patient with EGPA.
No takes yet. Share an insight, caveat, or question.
Naito et al. (2018) conducted a case report in Eosinophilic granulomatosis with polyangiitis (EGPA) with pulmonary embolism and deep vein thrombosis (n=1). Oral rivaroxaban vs. Low-molecular-weight heparin (LMWH) was evaluated on Improvement of thrombosis. Oral rivaroxaban dramatically improved deep vein thrombosis that had worsened during treatment with low-molecular-weight heparin in a patient with eosinophilic granulomatosis with polyangiitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: